• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西罗莫司治疗泛发性淋巴管瘤病疑似不良反应 1 例

A Case of Suspected Adverse Reactions to Sirolimus in the Treatment of Generalized Lymphatic Anomaly.

作者信息

Fujii Takayuki, Shimono Ryuichi, Tanaka Aya, Katami Hiroto

机构信息

Department of Pediatric Surgery, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Mikicho, Kitagun, Kagawa 761-0793, Japan.

出版信息

Case Rep Pediatr. 2019 Apr 30;2019:3101357. doi: 10.1155/2019/3101357. eCollection 2019.

DOI:10.1155/2019/3101357
PMID:31183237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6515074/
Abstract

Generalized lymphatic anomaly (GLA) is characterized by diffuse or multicentric proliferation of dilated lymphatic vessels resembling common lymphatic malformation, and thoracic lesions can be related to a poor prognosis. Sirolimus, an inhibitor of the mammalian target of rapamycin, is effective against vascular anomalies with few severe adverse drug reactions. Here, we report the case of a patient with intractable hemothorax pleural effusion due to GLA who was treated with sirolimus and experienced disseminated intravascular coagulation. Although a standard treatment for GLA has not been established, pleural fluid might be reduced using the Kampo medicine Eppikajyutsuto.

摘要

泛发性淋巴管异常(GLA)的特征是扩张的淋巴管呈弥漫性或多中心性增殖,类似于常见的淋巴管畸形,且胸部病变可能与预后不良有关。西罗莫司是一种雷帕霉素靶蛋白抑制剂,对血管异常有效,且严重药物不良反应较少。在此,我们报告一例因GLA导致难治性血胸性胸腔积液的患者,该患者接受西罗莫司治疗后发生了弥散性血管内凝血。虽然尚未确立GLA的标准治疗方法,但使用汉方药物薏苡仁汤可能会减少胸腔积液。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/6515074/36424f766a3f/CRIPE2019-3101357.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/6515074/96028e9d45c3/CRIPE2019-3101357.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/6515074/297a3c8fa27c/CRIPE2019-3101357.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/6515074/36424f766a3f/CRIPE2019-3101357.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/6515074/96028e9d45c3/CRIPE2019-3101357.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/6515074/297a3c8fa27c/CRIPE2019-3101357.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/6515074/36424f766a3f/CRIPE2019-3101357.003.jpg

相似文献

1
A Case of Suspected Adverse Reactions to Sirolimus in the Treatment of Generalized Lymphatic Anomaly.西罗莫司治疗泛发性淋巴管瘤病疑似不良反应 1 例
Case Rep Pediatr. 2019 Apr 30;2019:3101357. doi: 10.1155/2019/3101357. eCollection 2019.
2
Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA).西罗莫司治疗顽固性淋巴管畸形的疗效与安全性:一项开放标签、单臂、多中心前瞻性研究(SILA)的研究方案
Regen Ther. 2019 Jan 14;10:84-91. doi: 10.1016/j.reth.2018.12.001. eCollection 2019 Jun.
3
Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.全身性西罗莫司治疗弥漫性淋巴管畸形和 Gorham-Stout 病的疗效。
Pediatr Blood Cancer. 2019 May;66(5):e27614. doi: 10.1002/pbc.27614. Epub 2019 Jan 22.
4
Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial.西罗莫司治疗难治性淋巴管畸形:一项开放标签、单臂、多中心前瞻性试验。
Front Med (Lausanne). 2024 Feb 8;11:1335469. doi: 10.3389/fmed.2024.1335469. eCollection 2024.
5
Kaposiform Lymphangiomatosis in a Male Adolescent: A Clinical Challenge and the Role of Genetics.男性青少年卡波西样血管淋巴管瘤病:临床挑战及遗传学作用。
J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231166678. doi: 10.1177/23247096231166678.
6
Successful treatment of kaposiform lymphangiomatosis with sirolimus.西罗莫司治疗卡波西样血管淋巴管瘤病获得成功。
Pediatr Blood Cancer. 2015 Jul;62(7):1291-3. doi: 10.1002/pbc.25422. Epub 2015 Jan 18.
7
Chylothorax and constrictive pericarditis in a woman due to generalized lymphatic anomaly: a case report.一名女性因全身性淋巴管异常导致乳糜胸和缩窄性心包炎:病例报告
J Cardiothorac Surg. 2018 Jun 5;13(1):59. doi: 10.1186/s13019-018-0752-3.
8
Clinical Features and Prognosis of Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout Disease.泛发性淋巴管异常、卡波西样淋巴管瘤病和戈勒姆-斯托特病的临床特征与预后
Pediatr Blood Cancer. 2016 May;63(5):832-8. doi: 10.1002/pbc.25914. Epub 2016 Jan 25.
9
Sirolimus in the treatment of kaposiform lymphangiomatosis.西罗莫司治疗卡波西样淋巴管瘤病。
Orphanet J Rare Dis. 2021 Jun 8;16(1):260. doi: 10.1186/s13023-021-01893-3.
10
Generalized lymphatic anomaly successfully treated with long-term, low-dose sirolimus.长期低剂量西罗莫司成功治疗全身性淋巴管异常
Pediatr Dermatol. 2018 Jul;35(4):533-534. doi: 10.1111/pde.13494. Epub 2018 Mar 26.

本文引用的文献

1
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.西罗莫司治疗广泛和/或复杂慢血流血管畸形有效:单中心前瞻性 II 期研究。
Orphanet J Rare Dis. 2018 Oct 29;13(1):191. doi: 10.1186/s13023-018-0934-z.
2
A large retroperitoneal lymphatic malformation successfully treated with traditional Japanese Kampo medicine in combination with surgery.一例巨大腹膜后淋巴管畸形通过日本传统汉方医学联合手术成功治疗。
Surg Case Rep. 2017 Dec;3(1):80. doi: 10.1186/s40792-017-0358-3. Epub 2017 Jul 17.
3
Sirolimus in the Treatment of Vascular Anomalies.
西罗莫司在血管异常治疗中的应用
Eur J Pediatr Surg. 2017 Feb;27(1):86-90. doi: 10.1055/s-0036-1593383. Epub 2016 Oct 10.
4
Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis.日本血栓与止血学会关于弥散性血管内凝血新诊断标准的提案。
Thromb J. 2016 Sep 28;14:42. doi: 10.1186/s12959-016-0117-x. eCollection 2016.
5
Efficient Use of a Crude Drug/Herb Library Reveals Ephedra Herb As a Specific Antagonist for TH2-Specific Chemokine Receptors CCR3, CCR4, and CCR8.高效利用草药库揭示麻黄作为针对 TH2 特异性趋化因子受体 CCR3、CCR4 和 CCR8 的特异性拮抗剂。
Front Cell Dev Biol. 2016 Jun 7;4:54. doi: 10.3389/fcell.2016.00054. eCollection 2016.
6
Clinical Features and Prognosis of Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout Disease.泛发性淋巴管异常、卡波西样淋巴管瘤病和戈勒姆-斯托特病的临床特征与预后
Pediatr Blood Cancer. 2016 May;63(5):832-8. doi: 10.1002/pbc.25914. Epub 2016 Jan 25.
7
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.西罗莫司治疗复杂血管异常的疗效与安全性。
Pediatrics. 2016 Feb;137(2):e20153257. doi: 10.1542/peds.2015-3257. Epub 2016 Jan 18.
8
Clinical Efficacy of Herbal Medicine for Pediatric Lymphatic Malformations: A Pilot Study.草药治疗小儿淋巴管畸形的临床疗效:一项试点研究。
Pediatr Dermatol. 2016 Mar-Apr;33(2):191-5. doi: 10.1111/pde.12777. Epub 2016 Jan 17.
9
A case of mediastinal lymphangioma successfully treated with Kampo medicine.经方治疗纵隔淋巴管瘤 1 例
J Altern Complement Med. 2011 Jun;17(6):563-5. doi: 10.1089/acm.2010.0562. Epub 2011 May 13.
10
Rapamycin: something old, something new, sometimes borrowed and now renewed.雷帕霉素:旧物新用,时有借鉴,如今焕然一新。
Clin Pharmacol Ther. 2007 Oct;82(4):381-8. doi: 10.1038/sj.clpt.6100317. Epub 2007 Aug 29.